Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 10Infertility, Female 2Hyperandrogenism 2Thrombocytopenia 1Rectal Neoplasms 1Pre-Eclampsia 1Papillomavirus Infections 1Papilloma 1Neutropenia 1Menstruation Disturbances 1Lung Neoplasms 1Insulin Resistance 1Inflammation 1Infertility 1Hirsutism 1Diabetes, Gestational 1Cytopenia 1Colorectal Neoplasms 1Colonic Neoplasms 1Atypical Squamous Cells of the Cervix 1Anovulation 1Anemia 1Adenocarcinoma of Lung 1

Interventions

epigallocatechin gallate 1Vitamin B 12 1Narrow Band Imaging 1Lasers, Dye 1Hyaluronic Acid 1Folic Acid 13,3'-diindolylmethane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Papilloma × Folic Acid × Clear all
NCT05625308 2022-12-22

Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

Lo.Li.Pharma s.r.l

Phase NA Completed
40 enrolled

Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡